山口英世先生



Similar documents
Candida albicans In Vitro Diagnostics (13)--D-Glucan Determination Reagents

日本化学療法学会雑誌第50巻新薬特集号


untitled

名称未設定-1

37, 9-14, 2017 : cefcapene piperacillin 3 CT Clostridium difficile CD vancomycin CD 7 Clostridium difficile CD CD associate


特殊病態下感染症における抗菌薬治験の手引き作成委員会報告書(案)

50mg 75mg (1) H 3 C O OH HO H O O H OH SO H 3 Na H H N H 2 N NH OH H N O O H H O OH H 3 C H O O N H H H HO H NH CH 3 HN HO H OH O H OH H NH


小動物の皮膚真菌症

/‚“1/ŒxŒ{‚×›î’æ’¶

化学療法剤の適切な使い方について


Atlas_j060419

日本皮膚科学会雑誌第119巻第5号

病院感染対策ガイドライン(結核症)

Juntendo Medical Journal

Table 1. Antibacterial activitiy of grepafloxacin and other antibiotics against clinical isolates



Unknown

Key words: bacterial meningitis, Haemophilus influenzae type b, Streptococcus pneumoniae, rapid diagnosis, childhood

Key words: Streptococcus pyogenes, Streptococcus dysgalactiae subsp. equisimilis, rapid diagnosis

ICT 1 21 ICT., Cooper, Dawson

Fig. 1 Clinical findings and extent of inflammation area in female urethrocystitis Fig. 2 Classification and distribution of female patients with blad

History I COE

HILIC UPLC/MS UPLC LC/ MS LC/MS HPLC 2-4 HPLC 4,5 HILIC / HILIC 80 ACQUITY UPLC Xevo QTof MS ACQUITY BEH HILIC HILIC TOF ESI 1.7 µm BEH HILIC UPLC HIL

THE JAPANESE JOURNAL OF ANTIBIOTICS 65 6 Dec LVFX 100 mg 3 / mg 2 / LVFX PK PD mg mg 1 1 AUC/MIC

08サーベイ部会報告書v1117


J53-01


診療ガイドラインのカラクリ

微生物遺伝資源利用マニュアル(13)

深在性真菌症・スポロトリコーシス・クロモブラストミコーシスなら新しい皮膚科学|皮膚病全般に関する最新情報を載せた皮膚科必携テキスト

スライド 1

Valganciclovir 1 CMV valganciclovir VGCV CMV IgM CMV-DNA CMV 34 VGCV 2 1 CMV CMV ganciclovir valganciclovir MRI cytomegaloviru


Core Ethics Vol. : - NICU : : - A B C D

untitled






11月/庵原俊昭

SBP hospitalist network.key

* Meso- -scale Features of the Tokai Heavy Rainfall in September 2000 Shin-ichi SUZUKI Disaster Prevention Research Group, National R

Fig. 1 Trends of TB incidence rates for all forms and smear-positive pulmonary TB in Kawasaki City and Japan. Incidence=newly notified cases of all fo


9.プレゼン資料(小泉)R1

Microsoft Excelを用いた分子軌道の描画の実習

Annual Report 2015 アリアンツ生命保険の現状

Transcription:

Laboratory diagnosis of imported mycoses : how to safely execute laboratory examinations Hideyo YAMAGUCHI 5 1 6 1 1976 7 019-0395 359 Teikyo University Institute of Medical Mycology (TIMM) (359 Otsuka, Hachioji, Tokyo)

1986 8 coccidioidomycosis histoplasmosisparacoccidioidomycosisblastomycosis 4 penicillosis marneffei 5 endemic mycoses Endemic mycoses endemic mycoses 5 reservoir 1

Coccidioides spp. a Histoplasma capsulatum var. capsulatum b Histoplasma capsulatum var. duboisii c Histoplasma farciminosum d Paracoccidioides brasiliensis Penicillium marneffei Blastomyces dermatitidis 1 4 1 4 a C. immitis C. posadasii b c dh. capsulatum var. farciminosum 4 6 3 1

9 10 11 1 1997 007 10 3,436 10 9 1 1 4 HIV AIDS 90.1. 1 4 Medline http:www.pf.chibau.ac.jpyunyushinkinsyou-kanjya.html 1990 00 1995 1 AIDS

1 5 0 1950 H. capsulatum var. capsulatum00 H. capsulatum var. duboisii H. capsulatum var. farciminosum H. farciminosum 13 H. farciminosum H. capsulatum var. capsulatum 14 15, 16 0 1995 1999

5 118 8 17 dimorphism dimorphic fungus 5 30 37 Coccidioides spp. 37 Coccidioides immitis 1 18 189 Alejandro Posadas Coccidioides posadasii C. immitis Coccidioides spp. C. immitis C. posadasii PCR 19 1 PCR, 3 1 Coccidioides spp. H. capsulatum biohazard laboratory infection

biosafety biosafety level ; BSL BSL 1976 Pike 4 9 5 3 1990 C. immitis108 H. capsulatum81 Sporothrix schenckii13 B. dermatitidis1 P. marneffei 5, 6 S. schenckii 7 BSL 8 C. immitis 3b 3a BSL 3 C. immitis Coccidioides immitis 1 Blastomyces dermatitidis Histoplasma capsulatum Histoplasma farciminosum Paracoccidioides brasiliensis Penicillium marneffei Cryptococcus neoformans 3 Sporothrix schenckii Cladosporium carrionii 4 Cladosporium trichoides 4 C. bantianum Fonsecaea pedrosoi 4 Aspergillus fumigatus Candida albicans Exophiala dermatitidis 4 Microsporum canis 5 Trichophyton mentagrophytes 5 Trichophyton rubrum 5 3b 3a 3a c 3a 3a b b b b b a a a a a a BSL b 3 3 3 3 3 3 a 1ab3a3b 5 bbsl 4 134 BSL 3 c 1 Coccidioides posadasii H. capsulatum var. capsulatum H. capsulatum var. duboisii 3 C. neoformans var. neoformans C. neoformans var. gattii 4 5

C. immitis 1 10 9 H. capsulatum 30 BSL BSL 3 ASM 5 1 BSL BSL 3 BSL 3 31 33 1 C. immitis 34 David Stevens 35 X AIDS

BAL BAL BAL 3 1 DNA PCR PCR Coccidioides spp. 19 3 Coccidioides spp. H. capsulatum Coccidioides spp. H. capsulatum BSL AB BAL KOH

Y PAS Coccidioides spp. Coccidioides spp. Coccidioides spp. 70 36 AIDS Coccidioides spp. Coccidioides spp. PAS Gridley 400 3 4 H. capsulatum P. brasiliensis 400 Gridley 400 5 6 P. marneffei B. dermatitidis Brauer Dr. Scott Nelson, Department of Pamoxogy, UCLA, USA 400 BHI 1 SDAPDA 1 5 30 Coccidioides spp. a 4mm 0 60m Candida spp. C. glabratacr. neoformans, Prototheca spp. Histoplasma capsulatum Paracoccidioides brasiliensis Penicillium marneffei Blastomyces dermatitidis ac. immitis C. posadasii 4m 15 30mm 10m pilot s wheel 3 6m 8m 8 15m Coccidioides spp. P. marneffei C. glabrata, Cr. neoformans, Toxoplasma gondii H. capsulatum

H. capsulatum P. brasiliensis 4 5 30 P. marneffei PDA P. citrinum, P. purpurogenum, P. rubrum Penicillium spp. P. marneffei Coccidioides spp. 1 BHI BHI 37Coccidioides spp.p. marneffei 3 1Coccidioides spp. Histoplasma capsulatum SDA714 1Coccidioides spp. Histoplasma capsulatumsda71 3Paracoccidioides brasiliensis SDA718 4Paracoccidioides brasiliensis 1 37 7 3Paracoccidioides brasiliensissda718 43 5Penicillium marneffei 6Blastomyces dermatitidis 5Penicillium marneffeipda74 6Blastomyces dermatitidissda71 PDA75 SDA718 4

P. brasiliensis 3 37 4 10 704 48 DNA DNA Coccidioides spp. Converse YNB 37 CO 5 037 40 5 30 37 5 30 37 Coccidioides spp. 1 5 30 43 6m Histoplasma capsulatum Paracoccidioides brasiliensis Penicillium marneffei Blastomyces dermatitidis 5m 8 16m 3 10m PDA Penicillium 3m 10m 4m 3 10m 3m 5 30m

1 DNA RNA ITS DNA DNA PCR nested PCR PCR DNA DNA DNA DNA DNA DNA PCR DNA direct sequencing A Coccidioides spp. Coccidioides spp. H. capsulatum 1 1 Anaissie EJ, McGinnis MR, Pfaller MAed: Clinical Mycology, Churchill Livingstone, New YorkEdinburgh London Philadelphia, 003. 006 006. 3 007. 4 4 007. 5 Murray PR, Baron EJ, Jorgensen JH, et aled: Manual of Clinical Microbiology, 9th ed, ASM Press, Washington, DC, 007. 6 008. 7. : 1-16, 198. 8 p.96-106, 1986. 9 Coccidioidomycosis 1. : 968-973, 1984.

10 1. : 111, 1987. 11Cuellar-Rodriguez J, Avery RK, Lard M, et al : Histoplasmosis in solid organ transplant recipients : 10 years of experience at a large transplant center in an endemic area. Clin Infect Dis, : 710-716, 009. 1Stevens DA : The interface of mycology and endocrinology. J Med Vet Mycol, : 133-140, 1989. 13. : 36-45, 009. 14Manfredi R, Mazzoni A, Nanetti A, et al : Histoplasmosis capsulati and duboisii in Europe : The impact of the HIV pandemic, travel and immigration. Eur J Epidemiol, : 675-681, 1994. 15Symmers WC : Histoplasmosis contracted in Britain : a case of histoplasmic lymphadenitis following clinical recovery from sarcoidosis. Br Med J, : 786-790, 1956. 16Viviani MA, Vago G, Farina C, et al : ECMM Survey of histoplasmosis in Europe. Report from Italy. Rev Iberoamer Micol, : S143, 000. 17Ashbee HR, Evans EGV, Viviani MA, et al : Histoplasmosis in Europe : report on an epidemiological survey from the European Confederation of Medical Mycology Working Group. Med Mycol, : 57-65, 008. 18Fisher MC, Koenig GL, White TJ, et al : Molecular and phenotypic description of Coccidioides posadasii sp. nov., previously recognized as the non-california population of Coccidioides immitis. Mycologia, : 73-84, 00. 19Bialek R, Kern J, Herrmann T, et al : PCR assays for identification of Coccidioides posadasii based on the nucleotide sequence of the antigen proline-rich antigen. J Clin Microbiol, : 778-783, 004. 0Johnson SM, Simmons KA, Pappagianis D : Amplification of coccidioidal DNA in clinical specimens by PCR. J Clin Microbiol, : 198-1985, 004. 1Umeyama T, Sano A, Kamei K, et al : Novel approach to design primers for identification and distinction of the human pathogenic fungi Coccidioides immitis and Coccidioides posadasii by PCR amplification. J Clin Microbiol, : 1859-186, 006. Binnicker MJ, Buckwalter SP, Eisberner JJ, et al : Detection of Coccidioides species in clinical specimens by realtime PCR. J Clin Microbiol, : 173-178, 007. 3Sheff KW, York ER, Driebe EM, et al : Development of a rapid, cost-effective TaqMan real-time PCR assay for identification and differentiation of Coccidioides immitis and Coccidioides posadasii. Med Mycol, : 466-469, 010. 4Pike RM : Laboratory-associated infections. Summary and analysis of 391 cases. Health Lab Sci, : 105-114, 1976. 5Collins CH : Laboratory Acquired Infections, 3rd edn, Butterworth-Heinemann Ltd, Oxford, UK, 1993. 6Sewell DL : Laboratory-associated infections and biosafety. Clin Microbiol Rev, : 389-405, 1995. 7. : 0-9, 1993. 8 007. 9Walsh TJ, Pizzo PA : Nosocomial fungal infections : a classification for hospital-acquired fungal infections and mycoses arising from endogenous flora or reactivation. Ann Rev Microbiol, : 517-545, 1988. 30Pike RM : Laboratory-associated infections : incidence, fatalities, cases, and prevention. Ann Rev Microbiol, : 41-66, 1979. 31p.146-159 008. 3Warnock DW : Mycotic agents of human disease, p.110-10, Fleming DO, Hunt DLed, Biological Safety : Principles and Practices, ASM Press, Washington, DC, 000. 33Padhye AA, Bennett JE, McGinnis MR, et al : Biosafety considerations in handling medically important fungi. Med Mycol, : 58-65, 1998. 34Galgiani JN, Ampel NM, Blair JE, et al : Coccidioidomycosis. Clin Infect Dis, : 117-13, 005. 35Stevens DA, Clemons KV, Levine HB, et al : Expert opinion : what to do when there is Coccidioides exposure in a laboratory. Clin Infect Dis, : 919-93, 009. 36Kamei K, Sano A, Kikuchi K, et al : The trend of imported mycoses in Japan. J Infect Chemother, : 16-0, 003. 37. : 113-10, 1993.